RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.